|
2019
|
Invention
|
Compounds for treatment of fibrosis diseases.
The present invention relates to compounds as inhi... |
|
|
Invention
|
Compounds for treatment of cancer. The present invention relates to compounds as inhibitor of WNT... |
|
2018
|
Invention
|
Liposome formulation for delivery of wnt signal pathway inhibitor and a method for preparing the ... |
|
|
Invention
|
Liposome formulation for delivery of wnt signal pathway inhibitor. A liposome formulation for del... |
|
2017
|
Invention
|
Compounds for treatment of fibrosis diseases. The present invention relates to compounds as inhib... |
|
2016
|
Invention
|
Compound as wnt signaling inhibitor, composition, and use thereof. The present invention related ... |
|
2014
|
Invention
|
Quinazoline and naphthyridine derivatives useful in the treatment of cancer. The present in... |
|
|
Invention
|
Quinazoline and naphthyridine derivatives useful in the treatment of fibrotic disorders. The pres... |
|
2012
|
Invention
|
Compound as wnt signaling inhibitor, composition, and use thereof. The present invention relates ... |
|
|
Invention
|
Method for producing cardiomyocytes. The present invention provides a method for producing human ... |
|
2011
|
Invention
|
Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof. The prese... |
|
2010
|
Invention
|
Compound as wnt signaling inhibitor, composition, and use thereof. A compound as inhibitor of WNT... |
